Benefits of 5000 L single-use bioreactors
This white paper focuses on a new generation of single-use bioreactors, built to deliver high-volume performance and how they address many issue.
Abstract: This white paper focuses on a new generation of single-use bioreactors, built to deliver high-volume performance and how they address many issues:
· A demand for therapeutics
· Expanding indications for biologics
· The growing portfolios of biosimilars
If you are interested to read the whitepaper, please find more information here.
Biocytogen Co Ltd
Draupnir Bio ApS